(Total Views: 648)
Posted On: 08/24/2017 1:22:42 PM
Post# of 42
New Fact Sheet ....
http://files.shareholder.com/downloads/OCLS/4..._Sheet.pdf
Ø Pure play dermatology-focused company, building multi-technology platform
Ø Products based on core Microcyn®Technology and in-licensing
Ø Addressable dermatitis market of 16.5 million prescriptions or ~$1.5+ billion, with good pricing flexibility and profitability
Ø Double-digit US product revenue growth providing affordable, unique & effective products –launching one per
quarter
http://files.shareholder.com/downloads/OCLS/4..._Sheet.pdf
Ø Pure play dermatology-focused company, building multi-technology platform
Ø Products based on core Microcyn®Technology and in-licensing
Ø Addressable dermatitis market of 16.5 million prescriptions or ~$1.5+ billion, with good pricing flexibility and profitability
Ø Double-digit US product revenue growth providing affordable, unique & effective products –launching one per
quarter
(0)
(0)
